Viridian Therapeutics, Inc. VRDN Return on invested capital

Return on invested capital at other companies

AmgenAMGN

14.8%+3.6pp

Vera TherapeuticsVERA

-77.1%+219pp

RegenxbioRGNX

-103.9%+612pp

Zevra Therapeutics, Inc.ZVRA

71.7%+48.7pp

Shattuck Labs, Inc.STTK

-579.2%-1,580pp

Krystal Biotech, Inc.KRYS

24.3%+7.1pp

FAQ

What is Viridian Therapeutics, Inc.'s return on invested capital?

Viridian Therapeutics, Inc. (VRDN) reported return on invested capital of -78.5% in Q2 2026.

How has Viridian Therapeutics, Inc.'s return on invested capital changed year-over-year?

Viridian Therapeutics, Inc.'s return on invested capital increased by 8.6% year-over-year, from -85.9% to -78.5%.

What is the long-term trend for Viridian Therapeutics, Inc.'s return on invested capital?

Over 4 years (2021 to 2025), Viridian Therapeutics, Inc.'s return on invested capital has grown at a -2.7% compound annual growth rate (CAGR), from -72.4% to -64.8%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.